Bela Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.84 Cr
- Satisfied Charges ₹ 4.60 M
- Revenue Growth 6.98%
- Profit Growth 25.71%
- Ebitda -24.72%
- Net Worth 4.73%
- Total Assets -13.19%
About Bela Medical Agencies
Bela Medical Agencies Private Limited (BMAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 April 1996 and has a history of 28 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹1.84 Cr. The company has closed loans amounting to ₹4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Patel and Rinaben Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1996PTC029216
- Company No.
029216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Bela Medical Agencies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Patel  | Director | 03-Apr-1996 | Current |
| Rinaben Patel | Director | 31-Mar-1997 | Current |
Financial Performance of Bela Medical Agencies.
Bela Medical Agencies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.98% increase. The company also saw a substantial improvement in profitability, with a 25.71% increase in profit. The company's net worth moved up by a moderate rise of 4.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bela Medical Agencies?
In 2022, Bela Medical Agencies had a public holding of 21.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.42 M
₹4.60 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2023 | Hdfc Bank Limited | ₹8.13 M | Open |
| 28 Jul 2017 | Hdfc Bank Limited | ₹1.03 Cr | Open |
| 18 Jan 2001 | State Bank Of India | ₹0.60 M | Satisfied |
| 01 Apr 1997 | State Bank Of India | ₹4.00 M | Satisfied |
How Many Employees Work at Bela Medical Agencies?
Unlock and access historical data on people associated with Bela Medical Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bela Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bela Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
